Nalaganje...
Satraplatin in the treatment of hormone-refractory metastatic prostate cancer
Satraplatin is an orally bioavailable platinum chemotherapeutic agent under development for several cancer types, including hormone-refractory prostate cancer (HRPC). Satraplatin is being developed for the treatment of men with chemorefractory HRPC for several reasons: 1) relative ease of administra...
Shranjeno v:
| Main Authors: | , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Dove Medical Press
2007
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2376074/ https://ncbi.nlm.nih.gov/pubmed/18473011 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|